Wanhong Zhao

发表

Granulocyte colony stimulating factor priming chemotherapy is more effective than standard chemotherapy as salvage therapy in relapsed acute myeloid leukemia

Wanggang Zhang, Fangxia Wang, Xing-mei Cao, 2018, Medicina Clínica (English Edition).

Granulocyte colony stimulating factor priming chemotherapy is more effective than standard chemotherapy as salvage therapy in relapsed acute myeloid leukemia.

Wanggang Zhang, Fangxia Wang, Xing-mei Cao, 2017, Medicina clinica.

Mycophenolate mofetil as a treatment for refractory idiopathic thrombocytopenic purpura

Xing-mei Cao, Yin-xia Chen, A. He, 2005, Acta Pharmacologica Sinica.

Phase II, Open-Label Study of Ciltacabtagene Autoleucel, an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor–T-Cell Therapy, in Chinese Patients With Relapsed/Refractory Multiple Myeloma (CARTIFAN-1)

Saijuan Chen, Jianda Hu, J. Mi, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

Saijuan Chen, Hua Jiang, Jian-yong Li, 2022, Journal of Hematology & Oncology.

Construction and significance of directional expression cDNA library from human NB4 cells.

Jie Fu, Aizhi Zhao, Wanggang Zhang, 2004, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

B. Lei, Y. Geng, Zong-fang Li, 2018, Journal of Hematology & Oncology.

Focusing on long non‐coding RNA dysregulation in newly diagnosed multiple myeloma

Yan Peng, Fangxia Wang, A. He, 2018, Life sciences.

Expression profile analysis of long non‐coding RNA in acute myeloid leukemia by microarray and bioinformatics

Tian Liu, Liu-fang Gu, Fangxia Wang, 2018, Cancer science.

High-Intensity Chemotherapy is Associated with Better Prognosis in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma: A 10-Year Single-Center Retrospective Cohort Study

Wanggang Zhang, Xing-mei Cao, Yin-xia Chen, 2016, Medical science monitor : international medical journal of experimental and clinical research.

Chimeric Antigen Receptor T Cell Therapy in the Relapsed or Refractory Multiple Myeloma with Extramedullary Disease--a Single Institution Observation in China

B. Lei, Liu-fang Gu, Fangxia Wang, 2020 .

Interferon- and tumor necrosis factor- induce an immunoinhibitory molecule, B7-H1, via nuclear factor- B activation in blasts in myelodysplastic syndromes

Lieping Chen, K. Tamada, H. Tamura, 2010 .

Durable remissions with BCMA-specific chimeric antigen receptor (CAR)-modified T cells in patients with refractory/relapsed multiple myeloma.

B. Lei, Wanggang Zhang, Liu-fang Gu, 2017 .

Circ-ANAPC7 is Upregulated in Acute Myeloid Leukemia and Appears to Target the MiR-181 Family

Yuqiang Ji, Tian Liu, Juan Yang, 2018, Cellular Physiology and Biochemistry.

Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma

Zong-fang Li, B. Lei, Y. Geng, 2018, Blood.

Management of cytokine release syndrome related to CAR-T cell therapy

B. Lei, Wanggang Zhang, Liu-fang Gu, 2019, Frontiers of Medicine.

Combination chemotherapy with low‐dose cytarabine, homoharringtonine, and granulocyte colony‐stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia

Fangxia Wang, Xing-mei Cao, Yin-xia Chen, 2008, American journal of hematology.

Screening of novel immunostimulatory CpG ODNs and their anti-leukemic effects as immunoadjuvants of tumor vaccines in murine acute lymphoblastic leukemia.

Wanggang Zhang, Xing-mei Cao, A. He, 2011, Oncology reports.

High programmed death 1 expression on T cells in aplastic anemia.

Juan Yang, Wanggang Zhang, A. He, 2017, Immunology letters.

Serum soluble BCMA can be used to monitor relapse of multiple myeloma patients after chimeric antigen receptor T-cell immunotherapy.

A. He, Jie Liu, Baiyan Wang, 2023, Current research in translational medicine.

lncRNA ST3GAL6‑AS1 promotes invasion by inhibiting hnRNPA2B1‑mediated ST3GAL6 expression in multiple myeloma.

Jinsong Hu, A. He, Yue Peng, 2021, International journal of oncology.

Long-Term Follow-up of a Phase 1, First-in-Human Open-Label Study of LCAR-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Maturation Antigen (BCMA), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

B. Lei, Y. Geng, Zong-fang Li, 2019, Blood.

[Immunological screening for multiple myeloma-associated antigens and their bioinformatics analysis].

Ming Liu, Gang Chen, Xing-mei Cao, 2006, Zhongguo shi yan xue ye xue za zhi.

Pretreatment platelet-lymphocyte ratio versus neutrophil-lymphocyte ratio in the prognosis of multiple myeloma : a single center retrospective study

Wanggang Zhang, A. He, Jie Liu, 2019 .

Association of the four common polymorphisms in interleukin-10 (rs1800890, rs1800896, rs1800871, and rs1800872) with non-Hodgkin's lymphoma risk: a meta-analysis.

Z. Dai, Xing-mei Cao, Yin-xia Chen, 2014, International journal of clinical and experimental medicine.

Effects of CpG oligodeoxynucleotides on the differentiation of Treg/Th17 cells.

B. Lei, Yuqiang Ji, Wanggang Zhang, 2021, Molecular immunology.

[Therapeutic effects of porcine versus rabbit antithymocyte globulins for treatment of severe aplastic anemia].

Xing-mei Cao, Yin-xia Chen, A. He, 2016, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic era

Q. Cai, Xiansheng Liu, Yuan-Hong Chen, 2023, Experimental Hematology & Oncology.

[Retrospective observation of curative effects on MDS refractory anemia with combination of all-trans retinoic acid, 1, 25-dihydroxyvitamin D3 and androgen].

Xing-mei Cao, Yin-xia Chen, A. He, 2005, Zhongguo shi yan xue ye xue za zhi.

MLAA-34 knockdown shows enhanced antitumor activity via JAK2/STAT3 signaling pathway in acute monocytic leukemia

Yanping Zhang, B. Lei, Xin Meng, 2020, Journal of Cancer.

P874: LONG-TERM REMISSION AND SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AFTER TREATMENT OF LCAR-B38M CAR-T – AT LEAST 5-YEAR FOLLOW-UP IN LEGEND-2

Saijuan Chen, Zhu Chen, Jie Xu, 2023, HemaSphere.

Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report

Liu-fang Gu, Fangxia Wang, Xing-mei Cao, 2022, Journal of Medical Case Reports.

Effect of granulocyte colony-stimulating factor priming combined with low-dose cytarabine and homoharringtonine in higher risk myelodysplastic syndrome patients.

Liu-fang Gu, Wang-gang Zhang, Fangxia Wang, 2016, Leukemia research.

A comprehensive analysis of coagulopathy during anti‐B cell maturation antigen chimeric antigen receptor‐T therapy in multiple myeloma, a retrospective study based on LEGEND‐2

R. Liu, Wanggang Zhang, Fangxia Wang, 2023, Hematological oncology.

Indoleamine 2, 3-dioxygenase expression in cells of human acute monocyte leukemia (M(5)) and acute lymphocyte leukemia and therapeutic effect of its inhibitor 1-methyl tryptophan.

Yin-xia Chen, JingKang Sun, Yun Yang, 2007, Zhongguo shi yan xue ye xue za zhi.